Use of MALDI-TOF MS for Identification of Nontuberculous Mycobacterium Species Isolated from Clinical Specimens
暂无分享,去创建一个
María Concepción Mediavilla-Gradolph | I. de Toro-Peinado | M. P. Bermúdez-Ruiz | M. L. García-Martínez | María Ortega-Torres | N. Montiel Quezel-Guerraz | B. Palop-Borrás | María de los Ángeles García-Martínez | Begoña Palop-Borrás
[1] A. Steigerwalt,et al. Clinical and Laboratory Features of Mycobacterium porcinum , 2004, Journal of Clinical Microbiology.
[2] Robert Horsburgh,et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. , 2007, American journal of respiratory and critical care medicine.
[3] Markus Kostrzewa,et al. Comparison of MALDI-TOF MS with HPLC and nucleic acid sequencing for the identification of Mycobacterium species in cultures using solid medium and broth. , 2014, American journal of clinical pathology.
[4] S. Rüsch-Gerdes,et al. Evaluation of the GenoType Mycobacterium Assay for Identification of Mycobacterial Species from Cultures , 2006, Journal of Clinical Microbiology.
[5] Linda S. Guthertz,et al. Mycolic Acid Analysis by High-Performance Liquid Chromatography for Identification of Mycobacterium Species , 2001, Clinical Microbiology Reviews.
[6] S. Butler-Wu,et al. Comparison of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems for Identification of Mycobacteria Using Simplified Protein Extraction Protocols , 2013, Journal of Clinical Microbiology.
[7] U. Singh,et al. Rapid identification of clinical mycobacterial isolates by protein profiling using matrix assisted laser desorption ionization-time of flight mass spectrometry. , 2013, Indian journal of medical microbiology.
[8] E. Tortoli. Clinical manifestations of nontuberculous mycobacteria infections. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[9] V. Rotimi,et al. Comparative evaluation of two matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems for the identification of clinically significant yeasts. , 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[10] E. Mcgrath,et al. Increased prevalence of non-tuberculous mycobacteria infection , 2007, The Lancet.
[11] M. Slaný,et al. The influence of culture conditions on the identification of Mycobacterium species by MALDI-TOF MS profiling. , 2014, FEMS microbiology letters.
[12] P. Murray,et al. Identification of Mycobacteria in Solid-Culture Media by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry , 2011, Journal of Clinical Microbiology.
[13] U. Göbel,et al. Occurrence and Clinical Relevance of Mycobacterium chimaera sp. nov., Germany , 2008, Emerging infectious diseases.
[14] Y. Wang,et al. Comparison of Heat Inactivation and Cell Disruption Protocols for Identification of Mycobacteria from Solid Culture Media by Use of Vitek Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry , 2013, Journal of Clinical Microbiology.
[15] P. Berche,et al. Rapid Identification of Mycobacterial Whole Cells in Solid and Liquid Culture Media by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry , 2010, Journal of Clinical Microbiology.
[16] M. Almuzara,et al. Comparison of the Bruker MALDI-TOF Mass Spectrometry System and Conventional Phenotypic Methods for Identification of Gram-Positive Rods , 2014, PloS one.
[17] R. Kroppenstedt,et al. Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. , 2004, International journal of systematic and evolutionary microbiology.
[18] Brockhoff Ej,et al. Pulmonary Disease Associated with Nontuberculous Mycobacteria , 2011 .
[19] Paulette Legarraga,et al. [Impact of mass spectrometry by MALDI-TOF MS for the rapid identification of aerobic and anaerobic bacteria of clinical importance]. , 2013, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.
[20] E. Tortoli. Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s , 2003, Clinical Microbiology Reviews.
[21] C. TamaraLeiva. Evaluación de una técnica de hibridación reversa para identificación rápida de micobacterias en Chile , 2012 .
[22] Frank,et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis , 1993, Journal of clinical microbiology.
[23] M. Wei,et al. Nontuberculous Mycobacteria Infections in Immunocompromised Patients: Single Institution Experience , 2009, Journal of pediatric hematology/oncology.
[24] K. Winthrop,et al. Pulmonary Disease Associated with Nontuberculous Mycobacteria, Oregon, USA , 2011, Emerging infectious diseases.
[25] M. Raponi,et al. Advancement in the routine identification of anaerobic bacteria by MALDI-TOF mass spectrometry , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[26] A. Rodloff,et al. Discrimination of Enterobacteriaceae and Non-fermenting Gram Negative Bacilli by MALDI-TOF Mass Spectrometry , 2013, The open microbiology journal.
[27] T. Adékambi. Mycobacterium mucogenicum group infections: a review. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[28] Didier Raoult,et al. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. , 2006, International journal of systematic and evolutionary microbiology.
[29] P. García-Martos,et al. Infecciones por micobacterias de crecimiento rápido , 2012 .
[30] Laura Ferreira,et al. Aplicaciones de la proteómica en el laboratorio de Microbiología Clínica , 2012 .